Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2006
|
| In: |
Antimicrobial agents and chemotherapy
Year: 2006, Jahrgang: 50, Heft: 9, Pages: 3227-3228 |
| ISSN: | 1098-6596 |
| DOI: | 10.1128/AAC.00551-06 |
| Online-Zugang: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1128/AAC.00551-06 Verlag, lizenzpflichtig, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563530/ 
|
| Verfasserangaben: | Marcus J.P. Geist, Gerlinde Egerer, Jürgen Burhenne, Gerd Mikus |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1766544959 | ||
| 003 | DE-627 | ||
| 005 | 20220820033752.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210812s2006 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1128/AAC.00551-06 |2 doi | |
| 035 | |a (DE-627)1766544959 | ||
| 035 | |a (DE-599)KXP1766544959 | ||
| 035 | |a (OCoLC)1341420476 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Geist, Marcus Julian Peter |d 1981- |e VerfasserIn |0 (DE-588)136086713 |0 (DE-627)57715009X |0 (DE-576)300822995 |4 aut | |
| 245 | 1 | 0 | |a Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype |c Marcus J.P. Geist, Gerlinde Egerer, Jürgen Burhenne, Gerd Mikus |
| 246 | 3 | 0 | |a CYP2C9*2 / CYP2C9*2 |
| 264 | 1 | |c 2006 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.08.2021 | ||
| 700 | 1 | |a Egerer, Gerlinde |e VerfasserIn |0 (DE-588)105502168X |0 (DE-627)792516745 |0 (DE-576)167430882 |4 aut | |
| 700 | 1 | |a Burhenne, Jürgen |d 1963- |e VerfasserIn |0 (DE-588)1034228889 |0 (DE-627)745126987 |0 (DE-576)381858197 |4 aut | |
| 700 | 1 | |a Mikus, Gerd |e VerfasserIn |0 (DE-588)110903137 |0 (DE-627)691097941 |0 (DE-576)336988710 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Antimicrobial agents and chemotherapy |d Washington, DC : Soc., 1972 |g 50(2006), 9, Seite 3227-3228 |h Online-Ressource |w (DE-627)306316919 |w (DE-600)1496156-8 |w (DE-576)09718859X |x 1098-6596 |7 nnas |a Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype |
| 773 | 1 | 8 | |g volume:50 |g year:2006 |g number:9 |g pages:3227-3228 |g extent:2 |a Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype |
| 856 | 4 | 0 | |u https://doi.org/10.1128/AAC.00551-06 |x Resolving-System |x Verlag |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1563530/ |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210812 | ||
| 993 | |a Article | ||
| 994 | |a 2006 | ||
| 998 | |g 110903137 |a Mikus, Gerd |m 110903137:Mikus, Gerd |d 910000 |d 910100 |e 910000PM110903137 |e 910100PM110903137 |k 0/910000/ |k 1/910000/910100/ |p 4 |y j | ||
| 998 | |g 1034228889 |a Burhenne, Jürgen |m 1034228889:Burhenne, Jürgen |d 910000 |d 910100 |e 910000PB1034228889 |e 910100PB1034228889 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 105502168X |a Egerer, Gerlinde |m 105502168X:Egerer, Gerlinde |d 910000 |d 910100 |e 910000PE105502168X |e 910100PE105502168X |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 998 | |g 136086713 |a Geist, Marcus Julian Peter |m 136086713:Geist, Marcus Julian Peter |d 910000 |d 910300 |e 910000PG136086713 |e 910300PG136086713 |k 0/910000/ |k 1/910000/910300/ |p 1 |x j | ||
| 999 | |a KXP-PPN1766544959 |e 3966291541 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Marcus J.P. Geist, Gerlinde Egerer, Jürgen Burhenne, Gerd Mikus"]},"person":[{"display":"Geist, Marcus Julian Peter","role":"aut","given":"Marcus Julian Peter","family":"Geist"},{"family":"Egerer","display":"Egerer, Gerlinde","given":"Gerlinde","role":"aut"},{"family":"Burhenne","display":"Burhenne, Jürgen","role":"aut","given":"Jürgen"},{"display":"Mikus, Gerd","role":"aut","given":"Gerd","family":"Mikus"}],"origin":[{"dateIssuedDisp":"2006","dateIssuedKey":"2006"}],"recId":"1766544959","type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"part":{"volume":"50","text":"50(2006), 9, Seite 3227-3228","year":"2006","issue":"9","pages":"3227-3228","extent":"2"},"language":["eng"],"title":[{"title_sort":"Antimicrobial agents and chemotherapy","subtitle":"AAC","title":"Antimicrobial agents and chemotherapy"}],"pubHistory":["1.1972 -"],"name":{"displayForm":["publ. by the American Society for Microbiology"]},"titleAlt":[{"title":"AAC"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Washington, DC","publisher":"Soc.","dateIssuedDisp":"1972-","dateIssuedKey":"1972"}],"recId":"306316919","corporate":[{"display":"American Society for Microbiology","role":"isb"}],"note":["Gesehen am 09.06.21"],"disp":"Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotypeAntimicrobial agents and chemotherapy","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1496156-8"],"issn":["1098-6596"],"eki":["306316919"]}}],"note":["Gesehen am 12.08.2021"],"id":{"doi":["10.1128/AAC.00551-06"],"eki":["1766544959"]},"physDesc":[{"extent":"2 S."}],"language":["eng"],"title":[{"title":"Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype","title_sort":"Safety of voriconazole in a patient with CYP2C9*2/CYP2C9*2 genotype"}]} | ||
| SRT | |a GEISTMARCUSAFETYOFVO2006 | ||